Marcia Maria Chiquitelli Marques
Overview
Explore the profile of Marcia Maria Chiquitelli Marques including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paiva C, Silva A, Oliveira I, Guimaraes V, Lacerda D, Teixeira G, et al.
Cancer Control
. 2024 Aug;
31:10732748241272463.
PMID: 39140157
Introduction: Neoadjuvant endocrine therapy (NET) is recommended for the treatment of invasive breast cancer (BC), particularly luminal subtypes, in locally advanced stages. Previous randomized studies have demonstrated the benefits of...
2.
Causin R, Polezi M, Freitas A, Calfa S, Altei W, Dias J, et al.
Heliyon
. 2024 Aug;
10(14):e33933.
PMID: 39104474
Background: Extracellular vesicles (EVs), ubiquitously released by blood cells, facilitate intercellular communication. In cancer, tumor-derived EVs profoundly affect the microenvironment, promoting tumor progression and raising the risk of recurrence. These...
3.
Faldoni F, Bizinelli D, Souza C, Santana I, Marques M, Rainho C, et al.
Clin Epigenetics
. 2024 Jul;
16(1):89.
PMID: 38971778
Background: Inflammatory breast cancer (IBC) is a rare disease characterized by rapid progression, early metastasis, and a high mortality rate. Methods: Genome-wide DNA methylation analysis (EPIC BeadChip platform, Illumina) and...
4.
Retamales J, Daneri-Navarro A, Artagaveytia N, Alves da Quinta D, Abdelhay E, Podhajcer O, et al.
JCO Glob Oncol
. 2024 May;
10:e2300216.
PMID: 38723219
Purpose: Breast cancer mortality rates in Latin America (LA) are higher than those in the United States, possibly because of advanced disease presentation, health care disparities, or unfavorable molecular subtypes....
5.
Aguiar Freitas A, Nunes C, Mano M, Causin R, Calfa S, de Oliveira M, et al.
Future Oncol
. 2023 Dec;
20(1):25-38.
PMID: 38131283
Liquid biopsy is increasingly vital in monitoring neoadjuvant breast cancer treatment. This study collected plasma samples at three time points from participants in the Neoadjuvant Carboplatin in Triple Negative Breast...
6.
Aguiar Freitas A, Nunes C, Mano M, Causin R, Santana I, de Oliveira M, et al.
Sci Rep
. 2023 Dec;
13(1):21411.
PMID: 38049525
This exploratory analysis of the Neoadjuvant Carboplatin in Triple Negative Breast Cancer (NACATRINE) study aimed to identify the biomarkers of pathological complete response (pCR) in patients with triple-negative breast cancer...
7.
Souza C, Carneiro A, de Oliveira Lessa A, Lacerda D, Paiva C, Zorzetto M, et al.
Breast Cancer Res Treat
. 2023 Aug;
202(1):57-65.
PMID: 37578666
Background: Neoadjuvant chemotherapy (NACT) is the mainstay of treatment of stages II and III triple-negative breast cancer (TNBC). This study aims to evaluate if the addition of carboplatin to NACT...
8.
Komoto T, Nishimura F, Evangelista A, Freitas A, da Silva G, Silva W, et al.
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37445965
Breast cancer is responsible for 25% of all cancers that affect women. Due to its high heterogeneity pattern in clinical diagnosis and its molecular profile differences, researchers have been seeking...
9.
Zanon M, Scapulatempo-Neto C, Gama R, Marques M, Reis R, Evangelista A
Genes (Basel)
. 2023 Jun;
14(6).
PMID: 37372400
Adenoid cystic carcinoma (ACC) has been reported as the second most common carcinoma of the salivary glands. Few studies have associated miRNA expression with ACC aggressiveness. In this study, we...
10.
Causin R, Sussuchi da Silva L, Leal L, Possati-Resende J, Evangelista A, Matsushita G, et al.
Cancer Cytopathol
. 2023 Apr;
131(7):454-464.
PMID: 37069588
Background: Some studies reported that differential gene expression could be used as a biomarker for high-grade cervical lesion identification. The aim was to evaluate the gene expression profile of cervical...